LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
Clinical trial NCT03287947 · TERMINATED
Trial details
- NCT number
- NCT03287947
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2019-09-03
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.